Rchr
J-GLOBAL ID：200901067922801520
Update date: Feb. 01, 2024
Daiju Ichikawa
イチカワ ダイジュ | Daiju Ichikawa
Affiliation and department：
Job title：
Research Associate/Assistant Professor/Instructor
Research field (1)：
Immunology
Research theme for competitive and other funds (2)：
- 2019 - 2022 Overcoming resistance to new drug in hematological malignancy tageting LncRNA.
- 2016 - 2018 Identification of novel therapeutic target molecules and the molecular mechanism for refractory multiple myeloma
Papers (25)：
-
Kenichi Nagase, Goro Edatsune, Yuki Nagata, Junnosuke Matsudo, Daiju Ichikawa, Sota Yamada, Yutaka Hattori, Hideko Kanazawa. Thermally-modulated cell separation columns using a thermoresponsive block copolymer brush as a packing material for the purification of mesenchymal stem cells. Biomater Sci. 2021. 9. 21. 7054-7064
-
Matsushita M, Saito S, Yokoe S, Ichikawa D, Hattori Y. Characteristics of a novel target antigen against myeloma cells for immunotherapy. Vaccines. 2020. 8. 4. 1-13
-
Moriwaki Y, Kubo N, Watanabe M, Asano S, Shinoda T, Sugino T, Ichikawa D, Tsuji S, Kato F, Misawa H. Endogenous neurotoxin-like protein Ly6H inhibits alpha7 nicotinic acetylcholine receptor currents at the plasma membrane. Scientific Reports. 2020. 10. 1. 11996-11996
-
Nagase K, Ishii S, Ikeda K, Yamada S, Ichikawa D, Akimoto A.M, Hattori Y, Kanazawa H. Antibody drug separation using thermoresponsive anionic polymer brush modified beads with optimised electrostatic and hydrophobic interactions. Scientific Reports. 2020. 10. 1
-
Nagase K, Inanaga D, Ichikawa D, Mizutani Akimoto A, Hattori Y, Kanazawa H. Temperature-modulated cell-separation column using temperature-responsive cationic copolymer hydrogel-modified silica beads. Colloids and Surfaces B: Biointerfaces. 2019. 178. 253-262
ｍore...
MISC (1)：
-
ICHIKAWA Daiju. E3 ubiquitin ligase in T cell anergy. 臨床免疫・アレルギー科. 2014. 62. 4. 411-417
Lectures and oral presentations (36)：
-
Effect of Multiple Myeloma Therapeutics on Autophagy Pathway
(第80回日本癌学会学術総会 2021)
-
The study of signaling pathways contributing to immunogenic cell death in multiple myeloma
(第46回日本骨髄腫学会学術集会 2021)
-
A novel candidate for immunological target in treatment of multiple myeloma.
(An AACR Special Conference on Tumor Immunology and Immunotherapy 2019)
-
Dedifferentiation by reprogramming genes augments drug resistance and clonal growth in myeloma cells
(The 81th Annual Meeting of the Japanese Society of Hematology 2019)
-
Diverse molecular mechanisms of lenalidomide resistance in multiple myeloma cells
(The 81th Annual Meeting of the Japanese Society of Hematology 2019)
ｍore...
Return to Previous Page
